How to buy Inovio Pharmaceuticals (INO) shares in Australia
Learn how to easily invest in Inovio Pharmaceuticals shares.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Inovio Pharmaceuticals Inc is a biotechnology business with stocks listed in the US. Inovio Pharmaceuticals shares (INO) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was US$6.92 – a decrease of 3.89% over the previous week. Here's how to invest if you're based in Australia.
How to buy shares in Inovio Pharmaceuticals
- Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
- Search for Inovio Pharmaceuticals. Find the share by name or ticker symbol: INO. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Inovio Pharmaceuticals reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At last close price of US$6.9, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of Inovio Pharmaceuticals, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Inovio Pharmaceuticals. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
- Inovio Pharmaceuticals key stats
- Compare share trading platforms
- Is Inovio Pharmaceuticals stock a buy or sell?
- Inovio Pharmaceuticals performance over time
- Inovio Pharmaceuticals's financials
- How volatile are Inovio Pharmaceuticals shares?
- Does Inovio Pharmaceuticals pay a dividend?
- Have Inovio Pharmaceuticals shares ever split?
- Other common questions
Inovio Pharmaceuticals stock price (NASDAQ:INO)Use our graph to track the performance of INO stocks over time.
Inovio Pharmaceuticals shares at a glance
|52-week range||US$5.81 - US$19|
|50-day moving average||US$7.1924|
|200-day moving average||US$8.5005|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||US$-1.11|
Where to buy Inovio Pharmaceuticals stock
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy Inovio Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Considering buying Inovio Pharmaceuticals shares?Before you consider Inovio Pharmaceuticals, you'll want to hear this.
Ticker Nerd uses advanced software to track hundreds of signals and data points to find stocks before they blow up. You can get the next two hot stocks they find sent to your inbox for free.
Show me how
Inovio Pharmaceuticals price performance over time
|1 week (2021-11-19)||-5.85%|
|1 month (2021-10-26)||1.17%|
|3 months (2021-08-26)||-20.46%|
|6 months (2021-05-26)||-6.11%|
|1 year (2020-11-25)||-33.40%|
|2 years (2019-11-26)||174.60%|
|3 years (2018-11-26)||30.57%|
|5 years (2016-11-25)||-9.90%|
Stocks similar to Inovio Pharmaceuticals
Inovio Pharmaceuticals financials
|Revenue TTM||US$6.5 million|
|Gross profit TTM||US$-86,834,216|
|Return on assets TTM||-28.9%|
|Return on equity TTM||-56.86%|
|Market capitalisation||US$1.5 billion|
TTM: trailing 12 months
Inovio Pharmaceuticals share dividends
We're not expecting Inovio Pharmaceuticals to pay a dividend over the next 12 months.
Have Inovio Pharmaceuticals's shares ever split?
Inovio Pharmaceuticals's shares were split on a 1:4 basis on 6 June 2014. So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Inovio Pharmaceuticals shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for Inovio Pharmaceuticals shares which in turn could have impacted Inovio Pharmaceuticals's share price.
Inovio Pharmaceuticals share price volatility
Over the last 12 months, Inovio Pharmaceuticals's shares have ranged in value from as little as US$5.81 up to US$19. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Inovio Pharmaceuticals's is 0.5849. This would suggest that Inovio Pharmaceuticals's shares are less volatile than average (for this exchange).
Inovio Pharmaceuticals overview
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon optimized plasmids that have ability to help break the immune system's tolerance of cancerous or infected cells and facilitate cross-strain protection against unmatched and matched pathogen variants. The company is involved in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers, including cervical, vulvar, and anal dysplasia; HPV-associated cancers, including head and neck, cervical, anal, penile, vulvar, and vaginal; other HPV-associated disorders, such as recurrent respiratory papillomatosis; glioblastoma multiforme; prostate cancer; HIV; Ebola; Middle East Respiratory Syndrome (MERS); Lassa fever; Zika virus; and the COVID-19 virus (coronavirus). Its partners and collaborators include ApolloBio Corp., AstraZeneca, Beijing Advaccine Biotechnology Co., Ltd., The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations (CEPI), Defense Advanced Research Projects Agency (DARPA), HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, Medical CBRN Defense Consortium (MCDC), National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Ology Bioservices, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron, Thermo Fisher Scientific, University of Pennsylvania, Walter Reed Army Institute of Research, and The Wistar Institute. The company also has an agreement with Richter-Helm BioLogics GmbH & Co. KG to support investigational DNA vaccine INO-4800, which is currently in Phase I clinical testing for COVID-19; and a partnership with International Vaccine Institute and Seoul National University Hospital. The company was founded in 1979 and is headquart
Inovio Pharmaceuticals in the news
Inovio Pharmaceuticals Inc. stock rises Wednesday, still underperforms market
Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors
Inovio Pharmaceuticals Inc. stock underperforms Monday when compared to competitors
Frequently asked questions
More guides on Finder
Black Friday vacuum cleaner deals 2021: Dyson, Bosch and more
Get up to 58% off on robot cleaners to barrels and cordless sticks to all things Dyson during the Black Friday sales.
Nintendo Switch Black Friday deals 2021 Australia with up to 59% off
These are the best Black Friday deals for Nintendo Switch, including up to 59% off bestselling Switch games.
Black Friday TV deals in Australia: Up to $3,000 off smart TVs
The best Black Friday 2021 discounts include over $1,000 off 75-inch and 85-inch smart TVs from Samsung and Hisense.
Apple Watch Black Friday sales in Australia
Black Friday bargains include discounts on the Apple Watch Series 3 and Apple Watch accessories.
Black Friday mega deal: $162 off Nintendo Switch bundles
Get the Nintendo Switch bundled with Mario Kart 8 Deluxe and a 3-month Nintendo Switch Online subscription for $369 - save $160!
The best Black Friday headphone sales in Australia: Get up to 58% off
The biggest discounts include $200 off the Apple AirPods Max, 40% off the Beats Solo3, 38% off Jabra Elite 75t Earbuds and 56% off Sennheiser HD 400s.
Australia’s best Black Friday 2021 gaming laptop deals, save up to 40% off
Save over $1000 on gaming laptops during Black Friday 2021 from Dell, MSI, Lenovo, OMEN and Alienware and more.
Ask an Expert